Article

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions

2020-09-16

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor. These additional changes may be related to tumor progression and/or drug resistance. However, breast cancer-targeted NGS is not still widely used in clinical practice to compare the genomic profiles of pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d49b9bc1-3228-58b7-a4e6-48effb67bcc3
DOI: 10.21203/rs.2.16536/v5

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesionsDOI 10.21203/rs.2.16536/v5Read

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.Semantic proximity Read

Concordance of genomic alterations between primary and recurrent breast cancer.Semantic proximity Read

Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.Semantic proximity Read

Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers.Semantic proximity Read

Comparative genomic analysis of primary tumors and metastases in breast cancer.Semantic proximity Read

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.Semantic proximity Read

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatmentsSemantic proximity Read

Next‐generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug‐resistant recurrent ovarian cancerSemantic proximity Read

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapySemantic proximity Read

Genomic and transcriptomic evaluation of primary and recurrent luminal B-like breast cancer.Semantic proximity Read

Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.Semantic proximity Read

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.Semantic proximity Read